Key result
Prostaglandin E1 administration in infants with ductus dependent cardiac malformations resulted in pronounced pathological changes in the ductus arteriosus, rendering the vessel prone to laceration.
Why the study?
Does Prostaglandin E1 (PGE1) administration affect the histology of the ductus arteriosus in infants with ductus dependent cardiac malformations?
Case Report (n=4)
Does Prostaglandin E1 (PGE1) administration affect the histology of the ductus arteriosus in infants with ductus dependent cardiac malformations?
Answers are grounded in this paper and cite their sources.
Prostaglandin E1 administration in infants with ductus-dependent cardiac anomalies is associated with pronounced histological changes that weaken the ductus arteriosus wall, potentially increasing the risk of laceration.
The histology of the ductus arteriosus was studied after prostaglandin E1 (PGE1) administration in 4 infants with ductus dependent cardiac malformations. Pronounced pathological changes were found in each instance. The changes consisted of oedema of the media with separation of medial components by clear spaces, pathological interruptions of the internal elastic lamina, and intimal lacerations, some of which extended into the media. The findings suggest that PGE1 administration has a profound weakening effect on the structure of the wall of the ductus arteriosus, rendering the vessel prone to laceration.
No takes yet. Share an insight, caveat, or question.
Groot et al. (1978) conducted a case report in Ductus dependent cardiac malformations (n=4). Prostaglandin E1 (PGE1) was evaluated on Histology of the ductus arteriosus. Prostaglandin E1 administration in infants with ductus dependent cardiac malformations resulted in pronounced pathological changes in the ductus arteriosus, rendering the vessel prone to laceration.
Synapse has enriched 10 related papers. Consider them for comparative context: